Transatlantic Partnering in Biotech and Pharma in 2025: Navigating Choppy Waters
Our industry is undergoing a stress test. There are a multitude of destabilizing factors at play: As should be expected, biotech and pharma companies on both sides of the Atlantic are reevaluating their strategies. There has been a wave of announcements of large, long term investments in the US: Roche with $50 billion over ten […]
Collaboration Across the Atlantic: Why Strategic Alliances Matter More Than Ever in 2025
Imagine two scientists: one in Boston, another in Barcelona. Both driven by purpose, working on a molecule that could change lives. Yet between them lies not only the Atlantic Ocean, but layers of cultural nuance, regulatory divergence, and increasingly, political tension. In my presentation to the Futuro Perfecto community last year, I posed a simple […]
Integrations and tech transfer in biotech and pharma
In the world of biotechnology and the pharmaceutical industry, closing a deal is just the beginning of a much more complex process: operational integration, R&D collaboration, and technology transfer. During key events such as the J.P. Morgan Healthcare Conference (JPM), numerous mergers, acquisitions, and strategic partnerships are announced, but their real success is measured in their execution. Knowing how to integrate and transfer your technology is crucial.
How to strengthen strategic partnerships for 2025
How do we strengthen strategic partnerships? Are we maximizing the potential of our collaborations? How can we increase efficiency, reduce risks, and achieve a greater impact?
These are the questions you should be asking yourself about your alliances at least every six months.
Managing alliances is not just about the initial agreement but also about how it is executed daily. To ensure these partnerships generate value, you must evaluate their performance, adjust processes, and dynamically align strategies with your company’s objectives. Let’s dive into the details.
Challenges in biotechnology
Being resilient and able to overcome the challenges we encounter in drug discovery and development collaboration is what drives progress in biotech. Groundbreaking advancements come to those who work hard, are strategic, and who collaborate successfully (cross-functionally and with their partners). Operating in silos and working poorly with others will result in missed opportunities and failed programs.
Pitch deck for investors
In the biotech industry, having an innovative idea is not enough. To transform that idea into a viable company, you need funding. And to secure funding, you must capture the interest of the right investors. However, for many startups in the sector, finding the ideal financial partner remains the biggest challenge.
On August 29th
LBBAL™ Alianza is happy to participate in the webinar “Internationalization: From EU to North America” hosted by Futuro Perfecto USA. We will be sharing Best Practices to Set Up a Collaboration Across the Atlantic. If you are interested in this useful and free event, but are unable to attend live, registrants will receive a copy of the webinar recording. Full agenda and registration at https://internationalization.eventbrite.es/